AminAriaee_ Profile Banner
Amin Ariaee Profile
Amin Ariaee

@AminAriaee_

Followers
800
Following
165
Media
29
Statuses
145

PhD Candidate at @LabPrestidge 👨🏻‍🔬 | Supervisor @Paul_Joyce_| developing novel colonic microbiome-targeting delivery systems 💊 @microbiomeVIF Member 🦠

University of South Australia
Joined December 2021
Don't wanna be here? Send us removal request.
@AminAriaee_
Amin Ariaee
9 months
Excited to see our InuMCT microcapsules featured on @7NewsAdelaide 💊😊.
@7NewsAdelaide
7NEWS Adelaide
9 months
EXCLUSIVE: Many Aussies are fighting the battle of the bulge, but weight loss medications often only help in the short term. Now a new supplement being developed in SA could soon offer a natural long-term alternative. @AKunowski #7NEWS
0
0
8
@AminAriaee_
Amin Ariaee
11 months
RT @ClivePrestidge: @AminAriaee_ ‘s latest paper provides more insight into the performance of our inulin-lipid hybrid formulation. His PhD….
0
1
0
@AminAriaee_
Amin Ariaee
11 months
Here's our latest research on Inulin-coated MCT microcapsules!. In just 3 weeks of daily InuMCT in diet-induced obese rats, we saw:.✅ HDL up by 23%, glucose down by 15%, TNF-a normalised.↑ Microbiota diversity. InuMCT shows promise for obesity therapy!.
advanced.onlinelibrary.wiley.com
Spray-dried Inulin-medium chain triglyceride (InuMCT) microcapsules are innovative hybrid systems that enhance gut microbiota diversity, reduce weight gain, and improve HDL and glucose markers in...
0
2
12
@AminAriaee_
Amin Ariaee
1 year
RT @Paul_Joyce_: I am incredibly proud and excited to share our latest publication in @NatureNano defining the research quality standards n….
Tweet card summary image
nature.com
Nature Nanotechnology - The authors propose a framework to be followed during preclinical investigation of nanomedicines to increase their translatability potential.
0
17
0
@AminAriaee_
Amin Ariaee
1 year
RT @ClivePrestidge: ⁦@popatlab⁩ absolutely outstanding start to oral delivery at APDSC!!
Tweet media one
Tweet media two
Tweet media three
0
3
0
@AminAriaee_
Amin Ariaee
1 year
Very fortunate to have presented at #APDSC2024 ☺️.
@popatlab
Dr Amirali Popat
1 year
Great presentation from @AminAriaee_ on insulin-lipid hybrids for oral delivery. Great use of colours and presentation style #APDSC2024
Tweet media one
Tweet media two
0
2
8
@AminAriaee_
Amin Ariaee
1 year
What an amazing last week at the @CRSScience Annual Meeting and Exhibition in Bologna! Next stop on the conference tour ➡️ Copenhagen 🇩🇰. #CRS2024 @UniversitySA
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
11
@AminAriaee_
Amin Ariaee
1 year
🚀 Excited to share my latest publication in the Journal of Colloid and Interface Science entitled “Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion.”.
0
0
4
@AminAriaee_
Amin Ariaee
1 year
RT @ClivePrestidge: Congratulations @AminAriaee_ and @Amy_R_Logan in representing Australia at the CRS awards!
Tweet media one
Tweet media two
Tweet media three
0
1
0
@AminAriaee_
Amin Ariaee
1 year
RT @ClivePrestidge: A very big first day at CRS 2024 in sunny Bologna !
Tweet media one
Tweet media two
Tweet media three
0
1
0
@AminAriaee_
Amin Ariaee
1 year
RT @eGastro_BMJ: 🔬Gut bacteria and inflammatory bowel disease: a new frontier in treatment🔬.Please discover more via .🖇️.
0
3
0
@AminAriaee_
Amin Ariaee
1 year
Important gastro AEs for GLP-1 RAs 💊.
@DanielJDrucker
Daniel J Drucker
1 year
GLP-1 medicines produce adverse events, predominantly gastrointestinal, transient in most. Yet controversy continues surrounding what AEs are rare but real vs. alleged but not rigorously proven in RCTs or real world data. Free to read @DiabetesCareADA
Tweet media one
0
0
1
@AminAriaee_
Amin Ariaee
1 year
Feeling incredibly grateful to be selected alongside such remarkable researchers! Congratulations to all! 😊 #CRS @UniSA_CPI.
@CRS_FG_Oral
CRS Oral Delivery Focus Group
1 year
Congratulations for our @CRS_FG_Oral flash talk award winners @CRSScience #CRS AM 2024🎉🎉🎉
Tweet media one
1
0
9
@AminAriaee_
Amin Ariaee
1 year
RT @Paul_Joyce_: Great to see our important work on improving #mental_health medications making an impact. Thanks to @7NewsAdelaide @Gert….
0
1
0
@AminAriaee_
Amin Ariaee
1 year
Thrilled to have presented my research on novel microbiome-targeting oral delivery systems last night! What an incredible group of scientists. 🌟 #CRS #Microbiome @UniSA_CPI @UniversitySA.
@CRS_FG_Oral
CRS Oral Delivery Focus Group
1 year
ATTENTION📢📢! It is the time for our Flash Talk Contest !🎉 Join us the coming Wednesday 22/May, get prepared to be amazed by the 8 spark talks! @CRSScience @CRS_YSC @crs_wis @CRS_FG_NANO @CRS_FG_Immuno @CRS_FG_SkinMuco @CRS_FG_Ocular
Tweet media one
0
0
3
@AminAriaee_
Amin Ariaee
1 year
Check out our review ⬇️.
Tweet card summary image
egastroenterology.bmj.com
Inflammatory bowel disease (IBD) is characterised by chronic inflammation in the gastrointestinal tract, with unclear aetiology but with known factors contributing to the disease, including genetics,...
@DrHArmstrong
Dr. Heather Armstrong
1 year
🥳Exciting day with our manuscript led by PhD student Amin Ariaee from @Paul_Joyce_ lab @UniversitySA featured on the cover of eGastroenterology!.A really fantastic effort by Amin with our team aiming to highlight current evidence for #prebiotics in #IBD
Tweet media one
2
1
12
@AminAriaee_
Amin Ariaee
1 year
RT @eGastro_BMJ: 🌱 Explore the impact of prebiotics on inflammatory bowel disease treatment outcomes! Our latest review paper delves into p….
0
4
0
@AminAriaee_
Amin Ariaee
1 year
Our latest publication is out ⬇️ A detailed review on the impact of prebiotic selection - influencing outcomes in both animal models of colitis and human #IBD💊 .@eGastro_BMJ.
Tweet card summary image
egastroenterology.bmj.com
Inflammatory bowel disease (IBD) is characterised by chronic inflammation in the gastrointestinal tract, with unclear aetiology but with known factors contributing to the disease, including genetics,...
0
1
5